MatthewDallosMD

PubMed

• 1 citations
  Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer.
  Jessica E Hawley, Aleksandar Z Obradovic, Matthew C Dallos, Emerson A Lim, Karie Runcie, Casey R Ager, James McKiernan, Christopher B Anderson, Guarionex J Decastro, J...> ;Cancer Cell. 2023 Nov 13
• KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response.
  Casey R Ager, Mingxuan Zhang, Matthew Chaimowitz, Shruti Bansal, Somnath Tagore, Aleksandar Obradovic, Collin Jugler, Meri Rogava, Johannes C Melms, Patrick McCann, Ca...> ;Journal for Immunotherapy of Cancer. 2023 Sep 1
• 19 citations
  Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors.
  Shoiab Bukhari, Brian S Henick, Robert J Winchester, Shalom Lerrer, Kieran Adam, Yevgeniya Gartshteyn, Rohan Maniar, Ziyan Lin, Alireza Khodadadi-Jamayran, Aristotelis...> ;Cell Reports. Medicine. 2023 Jan 17
• 15 citations
  Prostate Cancer Immunotherapy-Finally in From the Cold?
  Karie Runcie, Matthew Dallos> ;Current Oncology Reports. 2021 Jun 14
• 59 citations
  Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses.
  David H. Aggen, Casey Ager, Aleksandar Obradovic, Nivedita Chowdhury, Ali Ghasemzadeh, Wendy Mao, Matthew G. Chaimowitz, Zoila A. Lopez-Bujanda, Catherine S. Spina, Je...> ;Clinical Cancer Research. 2021 Jan 15
• 53 citations
  T-cell infiltration and adaptive treg resistance in response to androgen deprivation with or without vaccination in localized prostate cancer
  Aleksandar Obradovic, Matthew Dallos, Marianna Zahurak, Alan W. Partin, Edward M. Schaeffer, Ashley E. Ross, Mohamad E. Allaf, Thomas R. Nirschl, David Liu, Carolyn Ch...> ;Clinical Cancer Research. 2020 Mar 15
• 5 citations
  Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy
  Jessica Hawley, Samuel Pan, William D. Figg, Zoila A. Lopez-Bujanda, Jonathan D. Strope, David H. Aggen, Matthew Dallos, Emerson A. Lim, Mark N. Stein, Jianhua Hu, Cha...> ;The Prostate. 2020 Mar 1
• 1 citations
  Prevention of Venous Thromboembolism in Pancreatic Cancer: Breaking Down a Complex Clinical Dilemma.
  Matthew C Dallos, Andrew B Eisenberger, Susan E Bates> ;The Oncologist. 2020 Feb 1
• 42 citations
  Immunotherapy in Prostate Cancer: Teaching an Old Dog New Tricks
  Michael C. Comiskey, Matthew Dallos, Charles G. Drake> ;Current Oncology Reports. 2018 Aug 18
• 17 citations
  Blocking PD-1/PD-L1 in Genitourinary Malignancies: To Immunity and Beyond.
  Matthew Dallos, Charles G. Drake> ;Cancer Journal. 2018 Jan 1
• 15 citations
  Current status of engineered T-cell therapy for synovial sarcoma.
  Matthew Dallos, William D. Tap, Sandra P. D'Angelo> ;Immunotherapy. 2016 Aug 3
• Join now to see all

Lectures

• Human prostate cancer immune phenotypes after androgen deprivation therapy. 
  2019 ASCO Annual Meeting - 6/1/2019